Detalles de la búsqueda
1.
Impact of childhood Dravet syndrome on care givers of patients with DS, a major impact on mothers.
Epilepsy Behav;
108: 107094, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32375095
2.
Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy.
Cost Eff Resour Alloc;
15: 11, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28701899
3.
Epidemiology of Distal Renal Tubular Acidosis: A Study Using Linked UK Primary Care and Hospital Data.
Nephron;
145(5): 486-495, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34198293
4.
Estimating public health and economic benefits along 10 years of Fluzone® High Dose in the United States.
Vaccine;
39 Suppl 1: A56-A69, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33509695
5.
An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany.
Expert Rev Pharmacoecon Outcomes Res;
17(1): 85-98, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27366939
6.
The use of Zostavax in Spain: the economic case for vaccination of individuals aged 50 years and older.
J Med Econ;
19(6): 576-86, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26808422
7.
Cost-effectiveness of everolimus plus reduced tacrolimus in de novo liver-recipients in the Italian setting.
J Med Econ;
19(9): 866-73, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27081739
8.
Systematic Literature Review and Meta-Analysis of Renal Function in Human Immunodeficiency Virus (HIV)-Infected Patients Treated with Atazanavir (ATV)-Based Regimens.
PLoS One;
10(5): e0124666, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25938588
9.
Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany.
Hum Vaccin Immunother;
11(4): 884-96, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25933182
10.
Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in previously untreated chronic hepatitis C genotype 1 patients.
J Med Econ;
17(1): 65-76, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24160335
11.
Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany.
J Health Econ Outcomes Res;
1(3): 239-253, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-37662876
12.
Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in treatment-experienced chronic hepatitis C genotype 1 patients.
J Med Econ;
17(1): 77-87, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24032626
13.
Cost utility of telaprevir-PR (peginterferon-ribavirin) versus boceprevir-PR and versus PR alone in chronic hepatitis C in The Netherlands.
Appl Health Econ Health Policy;
12(6): 647-59, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25103219
14.
Cost-effectiveness of highly purified omega-3 polyunsaturated fatty acid ethyl esters in the treatment of chronic heart failure: results of Markov modelling in a UK setting.
Eur J Heart Fail;
13(6): 681-9, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21474462
Resultados
1 -
14
de 14
1
Próxima >
>>